Novel radiotracer advantageous for imaging of neuroendocrine tumor patients

Reston, VA–For neuroendocrine cancer patients with liver metastases, a new radiopharmaceutical, 68Ga-DOTA-JR11, has shown excellent imaging performance in tumor detection, staging and restaging, providing important information to guide treatment. In a head-to-head comparison of two somatostatin receptor (SSTR) imaging agents, 68Ga-DOTA-JR11 PET/CT performed better than 68Ga-DOTATATE PET/CT in detecting liver metastases, with a better tumor-to-background…

Smart phones are empowering women worldwide

By giving women access to information they otherwise wouldn’t have, mobile phones are transforming lives. Putting smart phones in women’s hands could be a powerful tool to support sustainable development goals in the developing world, according to researchers from McGill University, University of Oxford and Bocconi University. The study published in Proceedings of the National…

Managing abnormal results on cervical cancer screening: ASCCP issues updated guidelines

June 25, 2020 – Replacing guidelines for managing women with abnormal results on cervical cancer screening test from 2012, new recommendations from ASCCP emphasize more precise management based on estimates of the patient’s risk – enabling more personalized recommendations for diagnosis, treatment, and follow-up. The revised guidelines with updated recommendations are now available in the…